Craig Millian

This profile gathers the share dealings of Craig Millian in HLS Therapeutics Inc. In total, 8 filings cover trades dated from 1 May 2023 to 20 August 2026.

Purchases make up the whole of the open-market record (5 purchases, €20k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant. Since January 2026: 3 purchases and no sales on the market.

In size, the median ticket on the buying side is €3,886. Across 5 purchases, this insider has always bought alone, with no colleague buying within 30 days.

On 24 August 2026 came the latest disclosure, an open-market purchase for €848 in HLS Therapeutics Inc. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.